KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Travere Therapeutics (TVTX) Non-Current Receivables (2016)

Travere Therapeutics (TVTX) has disclosed Non-Current Receivables for 3 consecutive years, with $46.2 million as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Non-Current Receivables changed N/A year-over-year to $46.2 million, compared with a TTM value of $46.2 million through Jun 2016, changed N/A, and an annual FY2015 reading of $45.6 million, changed N/A over the prior year.
  • Non-Current Receivables was $46.2 million for Q2 2016 at Travere Therapeutics, up from $45.9 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $46.2 million in Q2 2016 and bottomed at $137547.0 in Q1 2013.
  • Average Non-Current Receivables over 3 years is $34.5 million, with a median of $45.7 million recorded in 2015.